TC
TMO icon

TownSquare Capital’s Thermo Fisher Scientific TMO Stock Holding History

TownSquare Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$239K Buy
486
+20
+4% +$10.9K 0.05% 225
2025
Q4 		$270K Sell
466
-2,499
-84% -$1.41M 0.06% 207
2025
Q3 		$1.44M Sell
2,965
-4,633
-61% -$2.16M 0.22% 98
2025
Q2 		$3.08M Sell
7,598
-73,733
-91% -$30.8M 0.3% 74
2025
Q1 		$40.5M Buy
81,331
+2,999
+4% +$1.62M 0.43% 45
2024
Q4 		$40.8M Sell
78,332
-4,573
-6% -$2.51M 0.46% 41
2024
Q3 		$51.3M Buy
82,905
+3,447
+4% +$2.04M 0.61% 29
2024
Q2 		$43.9M Buy
79,458
+2,003
+3% +$1.15M 0.6% 32
2024
Q1 		$45M Buy
77,455
+27,534
+55% +$15.5M 0.66% 31
2023
Q4 		$26.5M Sell
49,921
-1,567
-3% -$758K 0.45% 49
2023
Q3 		$26.1M Buy
51,488
+1,422
+3% +$758K 0.48% 49
2023
Q2 		$26.1M Buy
50,066
+3,963
+9% +$2.14M 0.48% 50
2023
Q1 		$26.6M Sell
46,103
-951
-2% -$536K 0.59% 45
2022
Q4 		$25.9M Buy
47,054
+37,457
+390% +$19.8M 0.64% 37
2022
Q3 		$4.87M Sell
9,597
-302
-3% -$169K 0.14% 132
2022
Q2 		$5.38M Buy
9,899
+208
+2% +$114K 0.15% 119
2022
Q1 		$5.72M Buy
9,691
+221
+2% +$127K 0.15% 133
2021
Q4 		$6.32M Buy
9,470
+106
+1% +$66.2K 0.16% 114
2021
Q3 		$5.35M Buy
9,364
+335
+4% +$184K 0.15% 122
2021
Q2 		$4.67M Buy
9,029
+300
+3% +$142K 0.15% 121
2021
Q1 		$3.98M Buy
8,729
+94
+1% +$44.9K 0.15% 119
2020
Q4 		$4.02M Sell
8,635
-113
-1% -$53K 0.18% 109
2020
Q3 		$3.9M Sell
8,748
-1,316
-13% -$544K 0.23% 89
2020
Q2 		$3.81M Buy
10,064
+108
+1% +$36.2K 0.26% 77
2020
Q1 		$3.28M Sell
9,956
-1,285
-11% -$405K 0.27% 72
2019
Q4 		$3.65M Buy
11,241
+363
+3% +$110K 0.3% 69
2019
Q3 		$3.19M Buy
10,878
+479
+5% +$137K 0.26% 80
2019
Q2 		$2.86M Sell
10,399
-5,544
-35% -$1.53M 0.27% 74
2019
Q1 		$4.36M Buy
15,943
+9,213
+137% +$2.29M 0.34% 71
2018
Q4 		$1.66M Buy
+6,730
New +$1.58M 0.22% 91

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

TownSquare Capital's TMO Position: Q1 2026 in Review

TownSquare Capital increased its Thermo Fisher Scientific (TMO) stake by 4.3% in Q1 2026, buying an estimated $10.9K and bringing the position to 486 shares worth $239K. The position accounts for 0.05% of the portfolio, ranked #225.

TownSquare Capital first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $51.3M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • TownSquare Capital held 486 shares of Thermo Fisher Scientific worth $239K as of Q1 2026.
  • TownSquare Capital bought 20 Thermo Fisher Scientific shares in Q1 2026, an estimated $10.9K.
  • Thermo Fisher Scientific made up 0.05% of TownSquare Capital's portfolio in Q1 2026, its #225 holding.
  • TownSquare Capital first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • TownSquare Capital's Thermo Fisher Scientific position peaked at $51.3M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on TownSquare Capital's 13F filing for Q1 2026, filed 13 May 2026.